ANO1 and esophageal squamous cell carcinoma: Moreover, ANO1 not only promotes ESCC cell proliferation, migration, and invasion through the activation of the transforming growth factor β signaling pathway (173–175), but it also serves as a biomarker of poor prognosis in PDAC.